Pharmaceutical Excipients Market Hit to $8,439.0 Million by 2019 – New Research Report by MarketsandMarkets
(PRWEB) January 20, 2015 -- Pharmaceutical excipients are inactive ingredients used along with the active ingredients in a drug formulation. While excipients may have different functionalities, they generally do not affect the therapeutic action of the active ingredient. The demand for functional excipients is expected to record a strong growth in the forecast period due to its increased use in advanced drug delivery forms.
Full Copy Report @ http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html
The global pharmaceutical excipients market is majorly driven by patent cliffs resulting in increased demand of generic drugs, emergence of novel excipients, and growing demand of functional excipients. Use of modern science like nanotechnology to impart novel functions to the excipients used for target specific functionality of the active ingredients is also expected to propel the market for pharmaceutical excipients during the forecast period.
For Report Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=956
The pharmaceutical excipients market in this report is broadly segmented by products, functionality, and route of administration. The market by products is segmented into organic and inorganic chemicals. The market by functionality is segmented into fillers & diluents, binders, suspension & viscosity agents, coatings, flavouring agents, disintegrants, lubricats & glidants, colorants, and preservatives, while the market by route of administration covers oral, topical, parenteral, and other excipients.
The global pharmaceutical excipients market is expected to grow at a CAGR of 6.7% during the forecast period of 2014 to 2019. Swelling utilization of parenteral products owing to rise in the global burden of chronic and lifestyle diseases and heavy investments by the pharmaceutical industry on the development of biologic has propelled the growth of this market. Moreover, development of new APIs is increasing the demand of excipients like solubilizers and disintegrants which will further drive the growth of this market.
For PDF Manual @ http://www.marketsandmarkets.com/pdfdownload.asp?id=956
While developed regions like North America and Europe will show a sluggish growth, emerging markets like Asia-Pacific and Rest of the World is expected to record a strong growth during the forecast period. Countries like India, China, and Brazil will majorly drive the growth of these emerging markets owing to rising number of companies from the developed regions outsourcing their excipients manufacturing activities to these regions due to low manufacturing and labor costs in these countries.
Some of the prominent players in this market include Ashland Inc. (U.S.), BASF SE (Garmany), The Dow Chemical Company (U.S.), Roquette (France), Colorcon, Inc. (U.S.), Avantor Performance Materials, Inc. (U.S.), FMC Corporation (U.S.), Evonik Industries (Germany), and Lubrizol Corporation (U.S.). Various strategies such as collaborations, expansions, and new product launches have helped these companies maintain their market share and grow in this competitive market.
Related Reports:
Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nanofiltration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification, Sterilization, Virus Removal & Water Management), Region (North America, Europe, Asia-Pacific & ROW) - Trends & Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/pharmaceutical-membrane-filtration-market-255408031.html
Active Pharmaceutical Ingredient (API) Market Trends, Competitive Landscape and Global Forecasts (2011-2016)
http://www.marketsandmarkets.com/Market-Reports/API-Market-263.html
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
e-mail: [email protected]
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/pharmaceuticals
Mr. Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article